100 KING STREET WEST, TORONTO, A6
Enters Into $5.1 Million Warrant Inducement
Appoints Carolyn Bonner as Chief Financial Officer in Addition to Her Role as President
Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Medicus Pharma Ltd Completes $2.53M in Unregistered Share Sales
$8.0 MILLION NON-DILUTIVE DEBENTURE FINANCING
Changes in Board, Management or Compensation
COMPLETES ACQUISITION OF ANTEV LIMITED
Medicus Pharma Updates on D-MNA Clinical Program for BCC Treatment and Q2 2025 Financials
Q3
Q2
Q1
Amended Annual Report
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Definitive Proxy Statement
PRER14A
PRE 14A
Statement of Changes in Beneficial Ownership
Regulation A Offering Circular Supplement (Annual Report)